Atom Investors LP Amicus Therapeutics, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $108,480 - $182,599	-16,362 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$7.48 - $10.75 $122,387 - $175,891	16,362 New	16,362 $159,000
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $1.86 Million - $2.57 Million	-184,862 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $1.55 Million - $2.48 Million	184,862 New	184,862 $1.77 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.